$PHIL
PHI GROUP INC Stock $phil

$phil Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000149315223042104 Filed on November 20, 2023

Income Statement

Concept	2023 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$245.7K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$245.7K
YoY Change	-14.32%
Operating Profit	-$245.7K
YoY Change	-6.14%
Interest Expense	$43.68K
YoY Change	-85.59%
% of Operating Profit
Other Income/Expense, Net	-$2.744M
YoY Change	76.0%
Pretax Income	-$2.990M
YoY Change
Income Tax
% Of Pretax Income
Net Earnings	-$2.990M
YoY Change	64.19%
Net Earnings / Revenue
Basic Earnings Per Share	$0.00
Diluted Earnings Per Share	$0.00
COMMON SHARES
Basic Shares Outstanding	41.06B shares
Diluted Shares Outstanding	41.06B shares

Balance Sheet

Concept	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.780K
YoY Change
Cash & Equivalents	$3.778K
Short-Term Investments	$10.00
Other Short-Term Assets	$241.4K
YoY Change	-55.44%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$245.2K
YoY Change	-55.92%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$32.60K
YoY Change
Other Assets	$0.00
YoY Change
Total Long-Term Assets	$32.60K
YoY Change	-4.82%
TOTAL ASSETS
Total Short-Term Assets	$245.2K
Total Long-Term Assets	$32.60K
Total Assets	$277.8K
YoY Change	-52.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$616.1K
YoY Change	0.76%
Accrued Expenses	$2.049M
YoY Change	95.17%
Deferred Revenue	$1.079M
YoY Change	63.38%
Short-Term Debt	$1.490M
YoY Change	132.34%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$8.819M
YoY Change	28.59%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00
YoY Change
Other Long-Term Liabilities	$0.00
YoY Change
Total Long-Term Liabilities	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.819M
Total Long-Term Liabilities	$0.00
Total Liabilities	$8.819M
YoY Change	28.59%
SHAREHOLDERS EQUITY
Retained Earnings	-$80.31M
YoY Change	9.21%
Common Stock	$74.12M
YoY Change	9.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$44.17K
YoY Change	0.0%
Treasury Stock Shares
Shareholders Equity	-$8.541M
YoY Change
Total Liabilities & Shareholders Equity	$277.8K
YoY Change	-52.96%

Cashflow Statement

Concept	2023 Q3
OPERATING ACTIVITIES
Net Income	-$2.990M
YoY Change	64.19%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$622.5K
YoY Change	52.86%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$737.1K
YoY Change	4506.64%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$606.5K
YoY Change	71.68%
NET CHANGE
Cash From Operating Activities	-$622.5K
Cash From Investing Activities
Cash From Financing Activities	$606.5K
Net Change In Cash	-$15.99K
YoY Change	-70.38%
FREE CASH FLOW
Cash From Operating Activities	-$622.5K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	dei	Amendment Flag AmendmentFlag	false
CY2023Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q3	dei	Entity Central Index Key EntityCentralIndexKey	0000704172
CY2023Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2023Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2023Q3	PHIL	Cash In Transit CashInTransit		usd
CY2023Q3	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities		usd
CY2023Q3	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges		usd
CY2023Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets		usd
CY2023Q3	PHIL	Increase Decrease In Subfund Obligations IncreaseDecreaseInSubfundObligations		usd
CY2023Q3	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability		usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023Q3	dei	Document Type DocumentType	10-Q
CY2023Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q3	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
CY2023Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q3	dei	Entity File Number EntityFileNumber	001-38255-NY
CY2023Q3	dei	Entity Registrant Name EntityRegistrantName	PHI GROUP, INC.
CY2023Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	WY
CY2023Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-0114535
CY2023Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	2323 Main Street
CY2023Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Irvine
CY2023Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92614
CY2023Q3	dei	City Area Code CityAreaCode	714
CY2023Q3	dei	Local Phone Number LocalPhoneNumber	642-0571
CY2023Q3	dei	Security12b Title Security12bTitle	Common Stock
CY2023Q3	dei	Trading Symbol TradingSymbol	PHIL
CY2023Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
CY2023Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q3	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	43123215171	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3778	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19765	usd
CY2023Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5	usd
CY2023Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	420	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	241426	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	241426	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	245209	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	261611	usd
CY2023Q3	us-gaap	Long Term Investments LongTermInvestments	32598	usd
CY2023Q2	us-gaap	Long Term Investments LongTermInvestments	32604	usd
CY2023Q3	us-gaap	Assets Assets	277807	usd
CY2023Q2	us-gaap	Assets Assets	294215	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	616075	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	616245	usd
CY2023Q3	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	1624775	usd
CY2023Q2	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	1624775	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2048642	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1485310	usd
CY2023Q3	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	1672386	usd
CY2023Q2	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	1164685	usd
CY2023Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	218167	usd
CY2023Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	297805	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1079038	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1079038	usd
CY2023Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1220576	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1220576	usd
CY2023Q3	us-gaap	Liabilities Liabilities	8818800	usd
CY2023Q2	us-gaap	Liabilities Liabilities	8516217	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000000	shares
CY2023Q3	us-gaap	Preferred Stock Including Additional Paid In Capital PreferredStockIncludingAdditionalPaidInCapital	2440	usd
CY2023Q2	us-gaap	Preferred Stock Including Additional Paid In Capital PreferredStockIncludingAdditionalPaidInCapital	2440	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	42705215171	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42705215171	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39414493	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39414493	shares
CY2023Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1 for 1,500 reverse split
CY2022	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1 for 1,500 reverse split
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	42705215	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	39414493	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	31416653	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	32773102	usd
CY2023Q3	PHIL	Common Stock To Be Issued CommonStockToBeIssued	759562	usd
CY2023Q2	PHIL	Common Stock To Be Issued CommonStockToBeIssued	22500	usd
CY2023Q3	PHIL	Common Stock To Be Cancelled CommonStockToBeCancelled	35500	usd
CY2023Q2	PHIL	Common Stock To Be Cancelled CommonStockToBeCancelled	35500	usd
CY2023Q3	PHIL	Treasury Stock Common And Preferred Shares TreasuryStockCommonAndPreferredShares	484767	shares
CY2022Q2	PHIL	Treasury Stock Common And Preferred Shares TreasuryStockCommonAndPreferredShares	484767	shares
CY2023Q3	us-gaap	Treasury Stock Value TreasuryStockValue	44170	usd
CY2023Q2	us-gaap	Treasury Stock Value TreasuryStockValue	44170	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-80309276	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-77319372	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3035916	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3035495	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-8540992	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-8222002	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	277808	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	294215	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25000	usd
CY2023Q3	us-gaap	Salaries And Wages SalariesAndWages	52500	usd
CY2022Q3	us-gaap	Salaries And Wages SalariesAndWages	90000	usd
CY2023Q3	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	151854	usd
CY2022Q3	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	183915	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	41377	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12889	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	245731	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	286804	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-245731	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-261804	usd
CY2023Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	18	usd
CY2022Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	370	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	43677	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	303133	usd
CY2023Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	2700514	usd
CY2022Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1256446	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2744173	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1559209	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2989904	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1821013	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41055882399	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32373704704	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41055882399	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32373704704	shares
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2989904	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1821013	usd
CY2022Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	186	usd
CY2023Q3	PHIL	Net Change Due To Conversion Of Notes NetChangeDueToConversionOfNotes	-1804273	usd
CY2022Q3	PHIL	Net Change Due To Conversion Of Notes NetChangeDueToConversionOfNotes	-2082983	usd
CY2022Q3	PHIL	Cash In Transit CashInTransit	9500	usd
CY2022Q3	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-613309	usd
CY2022Q3	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	185965	usd
CY2022Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	185965	usd
CY2023Q3	PHIL	Increase Decrease In Accounts Payables IncreaseDecreaseInAccountsPayables	-170	usd
CY2022Q3	PHIL	Increase Decrease In Accounts Payables IncreaseDecreaseInAccountsPayables	-4350	usd
CY2022Q3	PHIL	Increase Decrease In Subfund Obligations IncreaseDecreaseInSubfundObligations	11844	usd
CY2023Q3	PHIL	Increase Decrease In Accrued Expenses IncreaseDecreaseInAccruedExpenses	563331	usd
CY2022Q3	PHIL	Increase Decrease In Accrued Expenses IncreaseDecreaseInAccruedExpenses	118268	usd
CY2022Q3	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-5000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	563161	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	120762	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-622470	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-407228	usd
CY2023Q3	PHIL	Proceeds From Financing Loans ProceedsFromFinancingLoans	25291	usd
CY2022Q3	PHIL	Proceeds From Financing Loans ProceedsFromFinancingLoans	41332	usd
CY2023Q3	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-105288	usd
CY2022Q3	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	378590	usd
CY2023Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	737062	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	16000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	606483	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	353258	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-15987	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-53970	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19764	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	67896	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3778	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13926	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-6543502	usd
	PHIL	Stock Issued During Value Conversions Of Promissory Notes StockIssuedDuringValueConversionsOfPromissoryNotes	233614	usd
	PHIL	Stock Issued During Value Exercise Of Warrants StockIssuedDuringValueExerciseOfWarrants	2395080	usd
	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	545710	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-6881906	usd
CY2023Q1	PHIL	Stock Issued During Value Conversions Of Promissory Notes StockIssuedDuringValueConversionsOfPromissoryNotes	1576175	usd
CY2023Q1	PHIL	Stock Issued During Value Conversions Of Promissory Notes StockIssuedDuringValueConversionsOfPromissoryNotes	1576175	usd
CY2023Q1	PHIL	Stock Issued During Value Shares Issued For Cash StockIssuedDuringValueSharesIssuedForCash	624865	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	185000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-8286628	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	974877	usd
CY2023Q2	PHIL	Stock Issued During Value Shares Issued For Cash StockIssuedDuringValueSharesIssuedForCash	919396	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-8222002	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-8222002	usd
CY2023Q3	PHIL	Stock Issued During Value Conversions Of Promissory Notes1 StockIssuedDuringValueConversionsOfPromissoryNotes1	102937	usd
CY2023Q3	PHIL	Stock Issued During Value Exercise Of Warrants1 StockIssuedDuringValueExerciseOfWarrants1	1756320	usd
CY2023Q3	PHIL	Stock Issued During Value Conversions Of Promissory Notes2 StockIssuedDuringValueConversionsOfPromissoryNotes2	75016	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-8540992	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-8540992	usd
CY2023Q3	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80E_eus-gaap--NatureOfOperations_z0Vqcgt0eeA9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">NOTE 1</span></b> – <b><span id="xdx_826_zYzgcVLnNbbe">NATURE OF BUSINESS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INTRODUCTION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PHI Group, Inc. (n/k/a Philux Global Group Inc) (the “Company” or “PHI”) (<span style="text-decoration: underline">www.philuxglobal.com</span>) is primarily engaged in mergers and acquisitions, advancing Philux Global Funds, SCA, SICAV-RAIF, a “Reserved Alternative Investment Fund” (“RAIF”) under the laws of Luxembourg, and developing the Asia Diamond Exchange in Vietnam. Besides, the Company provides corporate finance services, including merger and acquisition advisory and consulting services for client companies through our wholly owned subsidiary Philux Capital Advisors, Inc. (formerly PHI Capital Holdings, Inc.) (www.philuxcapital.com<span style="text-decoration: underline">)</span> and invests in selective industries and special situations aiming to potentially create significant long-term value for our shareholders. Philux Global Funds intends to include a number of sub-funds for investment in select growth opportunities in the areas of renewable energy, real estate, infrastructure, healthcare, agriculture, and the Asia Diamond Exchange in conjunction with the International Financial Center in Vietnam.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BACKGROUND</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Originally incorporated on June 8, 1982 as JR Consulting, Inc., a Nevada corporation, the Company applied for a Certificate of Domestication and filed Articles of Domestication to become a Wyoming corporation on September 20, 2017. In the beginning, the Company was foremost engaged in mergers and acquisitions and had an operating subsidiary, Diva Entertainment, Inc., which operated two modeling agencies, one in New York and one in California. In January 2000, the Company changed its name to Providential Securities, Inc., a Nevada corporation, following a business combination with Providential Securities, Inc., a California-based financial services company. In February 2000, the Company then changed its name to Providential Holdings, Inc. In October 2000, Providential Securities withdrew its securities brokerage membership and ceased its financial services business. Subsequently, in April 2009, the Company changed its name to PHI Group, Inc. From October 2000 to October 2011, the Company and its subsidiaries were engaged in various transactions in connection with mergers and acquisitions advisory and consulting services, real estate and hospitality development, mining, oil and gas, telecommunications, technology, healthcare, private equity, and special situations. In October 2011, the Company discontinued the operations of Providential Vietnam Ltd., Philand Ranch Limited, a United Kingdom corporation (together with its subsidiaries Philand Ranch - Singapore, Philand Corporation - US, and Philand Vietnam Ltd. - Vietnam), PHI Gold Corporation (formerly PHI Mining Corporation, a Nevada corporation), and PHI Energy Corporation (a Nevada corporation), and mainly focused on acquisition and development opportunities in energy and natural resource businesses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is currently focused on Philux Global Funds, SCA, SICAV-RAIF by launching Philux Global Select Growth Fund and potentially other sub-funds for investment in real estate, renewable energy, infrastructure, agriculture, healthcare and the International Financial Center and Asia Diamond Exchange in Vietnam. In addition, Philux Capital Advisors, Inc., a wholly owned subsidiary of the Company, continues to provide corporate and project finance services, including merger and acquisition (M&A) advisory and consulting services for U.S. and international companies. The Company has also formed Philux Global Advisors, Inc. to serve as the investment advisor to Philux Global Funds and other potential fund clients in the future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had signed agreements to acquire majority equity interests in Kota Construction LLC and Kota Energy Group LLC (“KOTA”) which are engaged in solar energy business (<span style="text-decoration: underline">https://www.kotasolar.com</span>), and Tin Thanh Group, a Vietnamese joint stock company (www.tinthanhgroup.vn) (“TTG”). Whereas the scheduled closing dates for the KOTA and TTG transactions already expired, the Company has continued to discuss with these companies and intends to renegotiate an revised agreement with each of them when the Company successfully closes one or more of the pending asset management agreements and financing with certain investor groups and lenders.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company intends to amend the Purchase and Sale Agreement that was originally signed on January 18, 2022 with Five-Grain Treasure Spirits Co., Ltd., a Chinese baiju distiller, to collaborate in launching American-made baiju products through Empire Spirits, Inc., a subsidiary of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2023, the Company signed a comprehensive business cooperation agreement with Dr. Tri Viet Do, a German-trained electromagnetic energy and quantum physics expert, to jointly develop and commercialize a number of key products using proprietary intellectual properties by him, with initial focus on clean energy generation and transportation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, in May 2023, the company signed a business cooperation agreement with SSE Global JSC, a Vietnamese joint stock company, to establish SSE Global Group, Inc., a Wyoming corporation, (<span style="text-decoration: underline">www.sseglobalgroup.com</span>) to commercialize a self-sustainable energy technology. The Company intends to integrate Dr. Tri Viet Do’s and SSE Global Group, Inc.’s technologies in the new subsidiary to be established in United Arab Emirates which will replace its former subsidiary CO2-1-0 (CARBON) Corp. to continue engaging in carbon emission mitigation using blockchain and crypto technologies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover, in June 2023 the Company signed a business cooperation agreement with Saphia Alkali JSC, a Vietnamese joint stock company, to form Sapphire Alkali Global Group in the United States to finance, manufacture, sell and distribute Saphia Alkali’s proprietary products on a worldwide basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These activities are disclosed in greater detail elsewhere in this report. No assurances can be made that the Company will be successful in achieving its plans.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BUSINESS STRATEGY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PHI’s strategy is to:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. Identify, build, acquire, commit and deploy valuable resources with distinctive competitive advantages;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. Identify, evaluate, acquire, participate and compete in attractive businesses that have large, growing market potential;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. Build an attractive investment that includes points of exit for investors through capital appreciation or spin-offs of business units.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2023Q3	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_zX710brXIjE4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zQL5wxHRlOO1">USE OF ESTIMATES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0118	pure
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
CY2023Q3	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_z1q2FN0I3AFa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zwqv1LtQHLa3">RISKS AND UNCERTAINTIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the normal course of business, the Company is subject to certain risks and uncertainties. The Company provides its service and receives marketable securities upon execution of transactions. Consequently, the value of the securities received from customers can be affected by economic fluctuations and each customer’s business growth. The actual realized value of these securities could be significantly different than recorded value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5	usd
CY2023Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5	usd
CY2023Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	420	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.393	pure
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	616075	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	616245	usd
CY2023Q3	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	1624775	usd
CY2023Q2	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	1624775	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2048642	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1485310	usd
CY2023Q3	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	1672386	usd
CY2023Q2	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	1164685	usd
CY2023Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	218167	usd
CY2023Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	297805	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	339141	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1027782	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1079038	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1079038	usd
CY2023Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1220576	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1220576	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	8818800	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	8516217	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2048642	usd
CY2023Q3	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	1080595	usd
CY2023Q3	us-gaap	Interest Payable Current InterestPayableCurrent	371158	usd
CY2023Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	1490198	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	819038	usd
CY2023Q3	us-gaap	Deposits Deposits	260000	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Treasury Stock Value TreasuryStockValue	44170	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3290721896	usd
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	42705215171	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42705215171	shares
CY2015Q1	us-gaap	Employee Stock Ownership Plan Esop Number Of Allocated Shares EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares	1000000	shares
CY2023Q3	PHIL	Common Stock To Be Issued CommonStockToBeIssued	759562	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-8540992	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2989904	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1821013	usd

Files In Submission

Name	View Source	Status
0001493152-23-042104-index-headers.html	Edgar Link	pending
0001493152-23-042104-index.html	Edgar Link	pending
0001493152-23-042104.txt	Edgar Link	pending
0001493152-23-042104-xbrl.zip	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
phil-20230930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
phil-20230930_cal.xml	Edgar Link	unprocessable
phil-20230930_def.xml	Edgar Link	unprocessable
phil-20230930_lab.xml	Edgar Link	unprocessable
phil-20230930_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PHIL
PHI GROUP INC Stock $phil

2023 Q3 Form 10-Q Financial Statement

#000149315223042104 Filed on November 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PHIL PHI GROUP INC Stock $phil

2023 Q3 Form 10-Q Financial Statement

#000149315223042104 Filed on November 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PHIL
PHI GROUP INC Stock $phil